Aera Therapeutics Stock

aeratx.comHealthcare / BioTech & PharmaFounded: 2021

Aera Therapeutics is a biotechnology and research company that develops new ways to deliver genetic medicine into cells. Through Aera’s proprietary protein nanoparticle (PNP) delivery platform, the Boston-based company is working to improve the treatment of human disease. The PNP platform is applied across a range of therapeutic applications.

Register To Buy and Sell Shares

For more details on financing and valuation for Aera Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Aera Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Aera Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Akin Akinc Ph.D
Chief Executive Officer
Feng Zhang Ph.D

Frequently Asked Questions About Aera Therapeutics’ Stock

Can you buy Aera Therapeutics’ stock?
Aera Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Aera Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Aera Therapeutics’ stock?
Yes, you can sell stock of a private company like Aera Therapeutics. Forge can help you sell your Aera Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Aera Therapeutics’ stock price?
Aera Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Aera Therapeutics’ private market stock price with Forge Data.
What is Aera Therapeutics’ stock ticker symbol?
Aera Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

A Refreshing Gamble on Crispr Delivery
A privately held biotech company called Aera Therapeutics came out of stealth recently to debut a type of protein nanoparticle that it believes can be used to ferry all sorts of genetic medicines around the body.
On hunt for better gene med delivery, Aera exits stealth with $193M and Alnylam vet at helm
Led by a 20-year Alnylam veteran, Aera Therapeutics has emerged with $193 million in hand and hopes of unlocking genetic medicine’s fullest potential.
Feng Zhang’s Delivery Platform Launched by Aera Therapeutics
Feng Zhang, PhD, institute member at the Broad Institute and HHMI Investigator, has an uncanny ability to be in the middle of (or on the leading edge of) the hottest topics in biological research.
Updated on: May 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.